title: Patients with heart failure and concomitant chronic obstructive pulmonary disease participating in the Heart Failure Pilot Survey (ESC-HF Pilot) - Polish population.
abstract: BACKGROUND
  There is an increasing interest in comorbidities in heart failure patients. Data about chronic obstructive pulmonary disease (COPD) in the Polish population of heart failure (HF) patients are scarce. The aim of this study was to investigate the clinical characteristics, treatment differences and outcome according to COPD occurrence in the Polish population of patients participating in the ESC-HF Pilot Survey Registry.
  
  
  METHODS
  We analyzed the data of 891 patients with HF recruited in 2009-2011 in Poland: 648 (72.7%) hospitalized patients and 243 (27.3%) patients included as outpatients.
  
  
  RESULTS
  The COPD was documented in 110 (12.3%) patients with HF in the analyzed population. Patients with - compared to those without COPD were older, more often smokers, had higher NYHA class, and higher prevalence of hypertension. Ejection fraction (EF) was higher in hospitalized patients with COPD compared to patients without COPD (40.5 ±14.6% vs. 37.2 ±13.7%, p < 0.04), without a significant difference in the outpatient group. There was a significant difference in β-blocker use between patients with and without COPD (81.8% vs. 94.7%, p < 0.0001). Most patients received them below target doses. At the end of the 12-month follow-up, there was no significant difference in mortality between COPD and no-COPD patients (10.9% vs. 11.1%, p = 0.66).
  
  
  CONCLUSIONS
  The findings from the Polish part of the ESC-HF registry indicate that COPD in patients with HF is associated with older age, smoker status, hypertension and higher NYHA class. The use of β-blockers was significantly lower in patients with than without COPD. There were no significant differences in mortality between groups.
authors: 1 Department of Cardiology, University Hospital "Przemienienia Pańskiego", Poznan University of Medical Sciences, Poznan, Poland.
authors: Ewa
authors: E
authors: Straburzyńska-Migaj
authors: 1 Department of Cardiology, University Hospital "Przemienienia Pańskiego", Poznan University of Medical Sciences, Poznan, Poland.
authors: Marta
authors: M
authors: Kałużna-Oleksy
authors: ANMCO Research Center, Florence, Italy.
authors: Aldo Pietro
authors: AP
authors: Maggioni
authors: 1 Department of Cardiology, University Hospital "Przemienienia Pańskiego", Poznan University of Medical Sciences, Poznan, Poland.
authors: Stefan
authors: S
authors: Grajek
authors: 1 Department of Cardiology, Medical University of Warsaw, Warsaw, Poland.
authors: Grzegorz
authors: G
authors: Opolski
authors: Department of Cardiology, 4 Military Hospital, Medical University of Wroclaw, Wroclaw, Poland.
authors: Piotr
authors: P
authors: Ponikowski
authors: Department of Cardiology, 4 Military Hospital, Medical University of Wroclaw, Wroclaw, Poland.
authors: Ewa
authors: E
authors: Jankowska
authors: 1 Department of Cardiology, Medical University of Warsaw, Warsaw, Poland.
authors: Paweł
authors: P
authors: Balsam
authors: 3 Chair and Department of Cardiology, Silesian Centre for Heart Diseases, Medical University of Silesia in Katowice, Medical Faculty in Zabrze, Poland.
authors: Lech
authors: L
authors: Poloński
authors: Department of Cardiology, Medical University of Lodz, Lodz, Poland.
authors: Jarosław
authors: J
authors: Drożdż
keywords: chronic heart failure; chronic obstructive pulmonary disease; β-blocker